2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...
³óºÎ½Éº¸, À¯¾Ø¾ÆÀ̰³¹ß·ÎºÎÅÍ 20¾ï¿ø ÅõÀÚ ¾àÁ¤ (2024-09-01)
Seequent and the International Geothermal Association Partne... (2024-12-07)
ÇÑÈ­Àδõ½ºÆ®¸®¾ó¼Ö·ç¼ÇÁî °ø½Ä Ãâ¹ü (2024-09-05)
ÇϹݱâ ä¿ë ÁøÇà ±â¾÷ 23³â 69.5% -> 24³â 42.1% (2024-08-12)
GS25, ³ÝÇø¯½º Çù¾÷ »óǰ 1000¸¸ °³ ÆÇ¸Å (2024-08-19)
hy, Ç︮ÄÚ¹ÚÅÍ ÇÁ·ÎÁ§Æ® Àª Áß±¹ ¼öÃâ (2024-10-03)
¡®¼³¹Î¼®ÀÇ Çѱ¹»ç ´ë¸ðÇè : À̼ø½ÅÀÇ ¸í·®ÇØÀü¡¯ üÇèÀü (2025-01-11)
Korea Zinc¡¯s Acquisition of Igneo Holdings Sparks Controver... (2025-01-11)
ÇÔ²²Çϴ½£ ¡®½£ üÇè ±³À°¡¯ Âü¿©±â°ü 95% ÀÌ»ó ¡®¸¸Á·¡¯ (2024-07-16)
¡®°íµù¾öºü¡¯ ÇϷ縸 ½Å¼¼Áö·Á´Ù°¡ µ¿°Å·Î...Ãâ»ê ÈÄ º»»ö µå·¯... (2024-06-19)
¡®¸¶¶ó °íÃß¹Ù»ç»è¡¯ Ãâ½Ã 3ÀÏ ¸¸¿¡ 8¸¸ ¸¶¸® ÆÇ¸Å µ¹ÆÄ (2023-11-12)
Xsolla Expands Leadership in Game Development and Innovation... (2024-12-08)
KB¼ÕÇØº¸Çè, ¡®KB Ç÷¯½º ¿îÀüÀÚ»óÇØº¸Ç衯 °³Á¤ Ãâ½Ã (2024-08-10)
±â¾Æ, Àå¾ÖÀÎ ¾ß±¸ °æ±â °ü¶÷ ÃÊû À̺¥Æ® (2024-10-04)
¡®¼Òµå ¿Àºê Äܹ߶󸮾ơ¯ ±Û·Î¹ú ´Ù¿î·Îµå 500¸¸ µ¹ÆÄ (2024-08-17)
ÀÌ´ë¿ì Çü»ç, 'È÷µç¾ÆÀÌ' õ¸¸ ¹è¿ì¿¡ µµÀü ÇÒ±î (2024-08-24)
Áö¿Àµð µ¥´Ï¾È, »ýÀϸÂÀÌ ´Üµ¶ ÆÒ¹ÌÆÃ (2024-12-05)
À§±â°¡±¸ ¹ß±¼Ã¼°è Ȱ¼ºÈ­ ¾ÕÀå... hy, ¼­¿ï½Ã¿Í MOU ü°á (2024-12-05)
JCB ½ÅÇÑÄ«µå·Î ¡®ÈÄÄí¿ÀÄ« ±³Åë ÅÍÄ¡°áÁ¦¡¯ ½Ã 50% ij½Ã¹é (2024-09-14)
¹æÅº¼Ò³â´Ü Áö¹Î¡¤ºß¡¤Á¤±¹, ³ë½ºÆäÀ̽º¿Í ¿Ïº®ÇÑ ÆÐ¼ÇÄÉ¹Ì (2024-10-08)
°ø°£ ±â¹Ý ¸ôÀÔÇü ¼Ò¼È Ç÷§Æû Ʋ·Î³ª, ÇÁ¸®½ÃÁð ¿ÀÇ (2024-08-28)
WÄÁ¼Á, ÀÎÇ÷ç¾ð¼­ 'ÀÌÀ¯Á¤'°ú ÇÔ²² ¿©¸§ ½ºÅ¸Àϸµ È­º¸ °ø°³ (2024-06-24)
The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatmen... (2024-12-02)
¼­¿ï °­¼­±¸, °íµ¶»ç ¹æÁö À§ÇØ ÅëÇÕ ½Ã½ºÅÛ ±¸Ãà (2024-09-04)
BROADMEDI and KHCA Sign Strategic MOU to Enhance Medical Tou... (2025-03-08)
       [ÀÌÀü][1]....[472][473][474][475][476][477][478][479][480]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..